DocuSign Reports Upbeat Q4 Results, Analysts Still Call lt A 'Wait-And-See' Story
1. DocuSign reported 9% YoY revenue growth, beating expectations. 2. Analysts maintained various price targets ranging from $90 to $124. 3. NRR (net recurring revenue) accelerated to 101%, indicating customer growth. 4. Management provided slightly below consensus guidance for Q1 FY26. 5. Shares increased by 15.52% to $86.30 after the results.